UHS
58
-2
VMC
54
-2
NTAP
67
2
ESS
70
-4
AEE
41
-9
LOW
43
-6
GS
70
4
MA
67
-2
HD
46
-4
PX
59
-3
MDT
41
-3
BA
43
-2
RIG
26
-2
CMG
61
-2
VZ
27
-2
WFC
58
-5
DOV
72
-4
NUE
34
-5
CPB
35
-5
ISRG
80
4
UHS
58
-2
VMC
54
-2
NTAP
67
2
ESS
70
-4
AEE
41
-9
LOW
43
-6
GS
70
4
MA
67
-2
HD
46
-4
PX
59
-3
MDT
41
-3
BA
43
-2
RIG
26
-2
CMG
61
-2
VZ
27
-2
WFC
58
-5
DOV
72
-4
NUE
34
-5
CPB
35
-5
ISRG
80
4
Financhill
Back

SPDR® Portfolio Emerging Markets ETF Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
60

SPEM
SPDR® Portfolio Emerging Markets ETF

Last Price:
37.66
Seasonality Move:
0.65%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.82
Seasonality Move:
-0.9%
Buy
60
SPDR® Portfolio Emerging Markets ETF (SPEM) is a Buy

Is SPDR® Portfolio Emerging Markets ETF a Buy, Sell or Hold?

  • The current SPDR® Portfolio Emerging Markets ETF [SPEM] share price is $37.66. The Score for SPEM is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • SPEM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.82. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SPEM Stock Price Chart

What is SPDR® Portfolio Emerging Markets ETF's stock price today?

  • The SPDR® Portfolio Emerging Markets ETF share price today is $37.66
    The current trend is moderately bearish and SPEM is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

SPEM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.13 Buy
Relative Strength Index (14 RSI): 48.33 Sell
Chaikin Money Flow: 958575 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.47 - 38.27) Sell
Bollinger Bands (100): (35.41 - 37.71) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.7 Sell
Relative Strength Index (14 RSI): 46.74 Sell
Chaikin Money Flow: 84619 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.82 - 42.02) Sell
Bollinger Bands (100): (40.86 - 48.8) Sell

SPEM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.01 Sell
20-day SMA: 37.75 Sell
50-day SMA: 37.36 Buy
200-day SMA: 35.33 Buy
8-day EMA: 37.92 Sell
20-day EMA: 37.83 Sell
50-day EMA: 37.42 Buy
200-day EMA: 35.92 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.53 Buy
20-day SMA: 40.36 Sell
50-day SMA: 41.57 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.71 Buy
20-day EMA: 40.38 Sell
50-day EMA: 41.84 Sell
200-day EMA: 43.38 Sell

SPDR® Portfolio Emerging Markets ETF Earnings Growth & SPEM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

SPDR® Portfolio Emerging Markets ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):